• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝集素样氧化型低密度脂蛋白受体(LOX-1)簇状组织功能意义的表面等离子体共振研究

Surface plasmon resonance study on functional significance of clustered organization of lectin-like oxidized LDL receptor (LOX-1).

作者信息

Ohki Izuru, Amida Hirokazu, Yamada Risato, Sugihara Mamoru, Ishigaki Tomoko, Tate Shin-ichi

机构信息

Graduate School of Biological Sciences, Nara Institute of Science and Technology, Ikoma, Nara 630-0198, Japan.

出版信息

Biochim Biophys Acta. 2011 Feb;1814(2):345-54. doi: 10.1016/j.bbapap.2010.10.006. Epub 2010 Oct 28.

DOI:10.1016/j.bbapap.2010.10.006
PMID:21035571
Abstract

Lectin-like oxidized low-density lipoprotein (OxLDL) receptor 1 (LOX-1) is the major OxLDL receptor of vascular endothelial cells and is involved in an early step of atherogenesis. LOX-1 exists as a disulfide-linked homodimer on the cell surface, which contains a pair of the ligand-binding domains (CTLD; C-type lectin-like domain). Recent research using living cells has suggested that the clustered state of LOX-1 dimer on the cell is functionally required. These results questioned how LOX-1 exists on the cell to achieve OxLDL binding. In this study, we revealed the functional significance of the clustered organization of the ligand-binding domain of LOX-1 with surface plasmon resonance. Biotinylated CTLD was immobilized on a streptavidin sensor chip to make CTLD clusters on the surface. In this state, the CTLD had high affinity for OxLDL with a dissociation constant (K(D)) in the nanomolar range. This value is comparable to the K(D) measured for LOX-1 on the cell. In contrast, a single homodimeric LOX-1 extracellular domain had lower affinity for OxLDL in the supra-micromolar range of K(D). Monomeric CTLD showed marginal binding to OxLDL. In combination with the analyses on the loss-of-binding mutant W150A, we concluded that the clustered organization of the properly formed homodimeric CTLD is essential for the strong binding of LOX-1 to OxLDL.

摘要

凝集素样氧化型低密度脂蛋白(OxLDL)受体1(LOX-1)是血管内皮细胞的主要OxLDL受体,参与动脉粥样硬化发生的早期步骤。LOX-1以二硫键连接的同二聚体形式存在于细胞表面,其中包含一对配体结合结构域(CTLD;C型凝集素样结构域)。最近使用活细胞的研究表明,细胞上LOX-1二聚体的聚集状态在功能上是必需的。这些结果引发了关于LOX-1如何在细胞上存在以实现与OxLDL结合的疑问。在本研究中,我们通过表面等离子体共振揭示了LOX-1配体结合结构域聚集组织的功能意义。将生物素化的CTLD固定在链霉亲和素传感器芯片上,以在表面形成CTLD簇。在这种状态下,CTLD对OxLDL具有高亲和力,解离常数(K(D))在纳摩尔范围内。该值与在细胞上测量的LOX-1的K(D)相当。相比之下,单个同二聚体LOX-1细胞外结构域对OxLDL的亲和力较低,K(D)在超微摩尔范围内。单体CTLD与OxLDL的结合很微弱。结合对结合缺失突变体W150A的分析,我们得出结论,正确形成的同二聚体CTLD的聚集组织对于LOX-1与OxLDL的强结合至关重要。

相似文献

1
Surface plasmon resonance study on functional significance of clustered organization of lectin-like oxidized LDL receptor (LOX-1).凝集素样氧化型低密度脂蛋白受体(LOX-1)簇状组织功能意义的表面等离子体共振研究
Biochim Biophys Acta. 2011 Feb;1814(2):345-54. doi: 10.1016/j.bbapap.2010.10.006. Epub 2010 Oct 28.
2
Structural implication for the impaired binding of W150A mutant LOX-1 to oxidized low density lipoprotein, OxLDL.W150A突变型凝集素样氧化低密度脂蛋白受体1(LOX-1)与氧化型低密度脂蛋白(OxLDL)结合受损的结构影响
Biochim Biophys Acta. 2012 May;1824(5):739-49. doi: 10.1016/j.bbapap.2012.02.003. Epub 2012 Feb 18.
3
Crystal structure of human lectin-like, oxidized low-density lipoprotein receptor 1 ligand binding domain and its ligand recognition mode to OxLDL.人凝集素样氧化型低密度脂蛋白受体1配体结合域的晶体结构及其对氧化型低密度脂蛋白的配体识别模式
Structure. 2005 Jun;13(6):905-17. doi: 10.1016/j.str.2005.03.016.
4
Chimeric structural stabilities in the coiled-coil structure of the NECK domain in human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1).人凝集素样氧化型低密度脂蛋白受体1(LOX-1)颈部结构域卷曲螺旋结构中的嵌合结构稳定性。
J Biochem. 2007 Jun;141(6):855-66. doi: 10.1093/jb/mvm093. Epub 2007 Apr 6.
5
Molecular mechanism of statin-mediated LOX-1 inhibition.他汀类药物介导的凝集素样氧化低密度脂蛋白受体-1(LOX-1)抑制的分子机制。
Cell Cycle. 2015;14(10):1583-95. doi: 10.1080/15384101.2015.1026486.
6
Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding.凝集素样氧化型低密度脂蛋白受体1(LOX-1)结构域内保守的C末端残基对于氧化型低密度脂蛋白的结合至关重要。
Biochem J. 2001 Apr 15;355(Pt 2):289-96. doi: 10.1042/0264-6021:3550289.
7
Requirements of basic amino acid residues within the lectin-like domain of LOX-1 for the binding of oxidized low-density lipoprotein.凝集素样氧化型低密度脂蛋白受体1(LOX-1)的凝集素样结构域内碱性氨基酸残基对氧化型低密度脂蛋白结合的要求
FEBS Lett. 2001 Jun 22;499(3):215-9. doi: 10.1016/s0014-5793(01)02557-1.
8
Lectin-like Oxidized Low-Density Lipoprotein (LDL) Receptor (LOX-1): A Chameleon Receptor for Oxidized LDL.凝集素样氧化型低密度脂蛋白(LDL)受体(LOX-1):一种氧化型LDL的变色龙受体。
Biochemistry. 2016 Aug 16;55(32):4437-44. doi: 10.1021/acs.biochem.6b00469. Epub 2016 Aug 4.
9
Functional refolding of a recombinant C-type lectin-like domain containing intramolecular disulfide bonds.含分子内二硫键的重组C型凝集素样结构域的功能重折叠
Protein Expr Purif. 2007 Apr;52(2):415-21. doi: 10.1016/j.pep.2006.11.012. Epub 2006 Dec 1.
10
"Affimer" synthetic protein scaffolds block oxidized LDL binding to the LOX-1 scavenger receptor and inhibit ERK1/2 activation.“Affimer” 合成蛋白支架可阻止氧化型 LDL 与 LOX-1 清道夫受体结合,并抑制 ERK1/2 的激活。
J Biol Chem. 2023 Nov;299(11):105325. doi: 10.1016/j.jbc.2023.105325. Epub 2023 Oct 5.

引用本文的文献

1
LOX-1 and cancer: an indissoluble liaison.LOX-1 与癌症:一种不可解的联系。
Cancer Gene Ther. 2021 Nov;28(10-11):1088-1098. doi: 10.1038/s41417-020-00279-0. Epub 2021 Jan 5.
2
Ecrg4 peptide is the ligand of multiple scavenger receptors.Ecrg4 肽是多种清道夫受体的配体。
Sci Rep. 2018 Mar 6;8(1):4048. doi: 10.1038/s41598-018-22440-4.
3
Homodimerization of the Lymph Vessel Endothelial Receptor LYVE-1 through a Redox-labile Disulfide Is Critical for Hyaluronan Binding in Lymphatic Endothelium.通过氧化还原不稳定的二硫键实现的淋巴管内皮受体LYVE-1的同源二聚化对于透明质酸在淋巴管内皮中的结合至关重要。
J Biol Chem. 2016 Nov 25;291(48):25004-25018. doi: 10.1074/jbc.M116.736926. Epub 2016 Oct 12.
4
The lectin-like oxidized LDL receptor-1: a new potential molecular target in colorectal cancer.凝集素样氧化型低密度脂蛋白受体-1:结直肠癌中一个新的潜在分子靶点。
Oncotarget. 2016 Mar 22;7(12):14765-80. doi: 10.18632/oncotarget.7430.
5
Membrane Cholesterol Modulates LOX-1 Shedding in Endothelial Cells.膜胆固醇调节内皮细胞中凝集素样氧化低密度脂蛋白受体1的脱落
PLoS One. 2015 Oct 23;10(10):e0141270. doi: 10.1371/journal.pone.0141270. eCollection 2015.
6
Molecular mechanism of statin-mediated LOX-1 inhibition.他汀类药物介导的凝集素样氧化低密度脂蛋白受体-1(LOX-1)抑制的分子机制。
Cell Cycle. 2015;14(10):1583-95. doi: 10.1080/15384101.2015.1026486.
7
Unveiling LOX-1 receptor interplay with nanotopography: mechanotransduction and atherosclerosis onset.揭示 LOX-1 受体与纳米拓扑结构的相互作用:力学转导与动脉粥样硬化起始。
Sci Rep. 2013;3:1141. doi: 10.1038/srep01141. Epub 2013 Jan 25.